Neuropeptide y genotype, central obesity, and abdominal fat distribution: The POUNDS LOST trial

American Journal of Clinical Nutrition

Volumn 102, Issue 2, 2015, Pages 514-519

  Lin, Xiaochen ^a,b   Qi, Qibin ^a,c   Zheng, Yan ^a   Huang, Tao ^a   Lathrop, Mark ^d,e   Zelenika, Diana ^f   Bray, George A ^g   Sacks, Frank M ^a   Liang, Liming ^a   Qi, Lu ^a,h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BROWN UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^g PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Dietary fat; Fat distribution; Gene nutrient interaction; Neuropeptide Y; SNP

Indexed keywords

NEUROPEPTIDE Y;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; ALLELE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; ABDOMINAL SUBCUTANEOUS FAT; BODY MASS; COMPARATIVE STUDY; DIET THERAPY; GENETIC ASSOCIATION; GENETICS; LIPID DIET; LOW CALORY DIET; METABOLISM; MIDDLE AGED; PATHOLOGY; WEIGHT GAIN; WEIGHT REDUCTION;

ABDOMINAL FAT; ADIPOSITY; ADULT; BODY MASS INDEX; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIET, REDUCING; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NEUROPEPTIDE Y; OBESITY, ABDOMINAL; POLYMORPHISM, SINGLE NUCLEOTIDE; SUBCUTANEOUS FAT, ABDOMINAL; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT LOSS;

EID: 84938696420     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.107276     Document Type: Article

References (36)

1. Ding B, Kull B, Liu Z, Mottagui-Tabar S, Thonberg H, Gu HF, Brookes AJ, Grundemar L, Karlsson C, Hamsten A, et al. Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept 2005;127:45-53.
2. Lin S, Boey D, Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004;38:189-200.
3. Dryden S, Pickavance L, Frankish HM, Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 1995;690:185-8.
4. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007;13:803-11.
5. Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005;202:1527-38.
6. Pedrazzini T, Brunner HR, Waeber B. Neuropeptide Y and cardiovascular regulation. Curr Opin Nephrol Hypertens 1993;2:106-13.
7. Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. Neuropeptide y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension 2012;60:1169-75.
8. Rosmaninho-Salgado J, Marques AP, Estrada M, Santana M, Cortez V, Grouzmann E, Cavadas C. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-gamma expression. Peptides 2012;37:49-54.
9. Baker SB, Cohen M, Kuo L, Johnson M, Al-Attar A, Zukowska Z. The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Plast Reconstr Surg 2009;123:486-92.
10. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004;116:337-50.
11. Tatemoto K. Neuropeptide Y: history and overview. In: Michel MC, editor. Neuropeptide Y and related peptides. Springer (Berlin Heidelberg) 2004. p. 1-21.
12. Yeung EH, Zhang C, Chen J, Bowers K, Hu FB, Kang G, Qi L. Polymorphisms in the neuropeptide Y gene and the risk of obesity: findings from two prospective cohorts. J Clin Endocrinol Metab 2011; 96:E2055-62.
13. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008;452: 997-1001.
14. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, Nelson S, Wang L, Connelly JJ, et al. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet 2009;5:e1000318.
15. Buckland PR, Hoogendoorn B, Guy CA, Coleman SL, Smith SK, Buxbaum JD, Haroutunian V, O?Donovan MC. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim Biophys Acta 2004;1690:238-49.
16. Kim NS, Oh SM, Ko MM, Cha MH, Kang BK, Bang OS. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke. Clin Biochem 2009;42:1699-704.
17. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
18. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokinemediated process? Diabetes 2002;51:2951-8.
19. Kirkland JL, Dobson DE. Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. J Am Geriatr Soc 1997;45:959-67.
20. Zhang W, Cline MA, Gilbert ER. Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism. Nutr Metab 2014;11:27.
21. Kos K, Harte AL, James S, Snead DR, O?Hare JP, McTernan PG, Kumar S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am J Physiol Endocrinol Metab 2007;293:E1335-40.
22. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859-73.
23. Williamson DA, Anton SD, Han H, Champagne CM, Allen R, LeBlanc E, Ryan DH, McManus K, Laranjo N, Carey VJ, et al. Adherence is a multi-dimensional construct in the POUNDS LOST trial. J Behav Med 2010;33:35-46.
24. Stricker-Krongrad A, Cumin F, Burlet C, Beck B. Hypothalamic neuropeptide Y and plasma leptin after long-term high-fat feeding in the rat. Neurosci Lett 1998;254:157-60.
25. Velkoska E, Cole TJ, Morris MJ. Early dietary intervention: long-term effects on blood pressure, brain neuropeptide Y, and adiposity markers. Am J Physiol Endocrinol Metab 2005;288:E1236-43.
26. Belsky J, Pluess M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull 2009;135:885-908.
27. Gauderman W, Morrison J. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies [Internet]. 2006. [cited 2015 Jun 26]. Available from: http://biostats. usc.edu/software.
28. Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation 2011;124:563-71.
29. Olza J, Gil-Campos M, Leis R, Ruperez AI, Tojo R, Canete R, Gil A, Aguilera CM. Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children. Peptides 2013;45:22-7.
30. Hohmann S, Buchmann AF, Witt SH, Rietschel M, Jennen-Steinmetz C, Schmidt MH, Esser G, Banaschewski T, Laucht M. Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development. Pediatr Obes 2012;7: 453-60.
31. Yamada T, Katagiri H, Ishigaki Y, Ogihara T, Imai J, Uno K, Hasegawa Y, Gao J, Ishihara H, Niijima A, et al. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab 2006;3:223-9.
32. Shi YC, Lin S, Castillo L, Aljanova A, Enriquez RF, Nguyen AD, Baldock PA, Zhang L, Bijker MS, Macia L, et al. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) 2011;19:2137-48.
33. Ruipan Z, Xiangzhi M, Li L, Ying Z, Mingliang Q, Peng J, Jingwei L, Zijun Z, Yan G. Differential expression and localization of neuropeptide Y peptide in pancreatic islet of diabetic and high fat fed rats. Peptides 2014;54:33-8.
34. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjonneland A, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-20.
35. Bastien M, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014;56:369-81.
36. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998;68:899-917.